|
DEPO 1. General Background – Depo-Provera is an injectable birth control containing medroxyprogesterone. It prevents ovulation for 12-14 weeks but has led to serious complications for some users. 2. Qualifying Injuries – Only individuals diagnosed with cerebral meningioma (malignant or benign) after using Depo-Provera are eligible. 3. Eligibility Criteria – Patients must have received at least four consecutive injections after 1992, used the shot for at least 12 months, and had a minimum two-year latency period before diagnosis. Additional conditions include being biologically female, knowing the location of administration, and not being diagnosed in restricted states (AL & MI before Feb. 13, 2024; LA, KY, TN, MS & TX). Legal considerations such as the statute of limitations (SOL) apply. 4. Legal Representation & Identification – Eligible claimants must not have legal representation and must possess a valid U.S. Social Security Number, though full SSNs are not collected. 5. Defendants – The legal case targets major pharmaceutical companies, Pfizer, Upjohn, and Mylan, as responsible parties. |
Please fill out the form below and a represenative will contact you as soon as possible